caprotec bioanalytics appoints Prof. Dr. Metternich as Managing Director, Chief Business Officer and Chief Operating Officer
caprotec bioanalytics GmbH announced the appointment of Prof. Dr. Rainer Metternich as Managing Director, Chief Business Officer and Chief Operating Officer of the company. Prior to joining caprotec, Prof. Metternich held senior leadership positions at Merck & Co., Schering AG and Novartis.
Before joining caprotec, Prof. Metternich was Vice President and Basic Research Site Head at Merck & Co in West Point, PA. Prior to that, he was Executive Vice President and Member of the Executive Committee at Schering AG in Berlin, and, before that, was Global Senior Chemistry Expert at Novartis in Basel. He earned his doctorate degree in organic chemistry from the University at Marburg, Germany, was a postdoctoral fellow at Harvard University with Professor David A. Evans and spent a Sabbatical at the University of California, Berkeley with Professor Paul A. Bartlett. He is on the editorial board of several leading scientific journals and a member of several Scientific Advisory Boards of academic, private and non-profit research organizations.
Most read news
Topics
Organizations
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Laryngeal_mask_airway

Happy hour for time-resolved crystallography - Researchers simplify time-resolved X-ray crystallography
Testing the Efficacy of New Gene Therapies More Efficiently

Scorpion venom to shuttle drugs into the brain - Chlorotoxin, a small protein with blood-brain barrier permeability modified to drug the brain

New approach explains how protein complexes regulate cancer genes - New starting point for improved cancer therapies
Category:Pharmaceutical_microbiology
Cipher receives Patent Notice of Allowance for CIP-ISOTRETINOIN

More efficient biosolar cells modelled on nature - By combining light-collecting and photosynthesis proteins of different types, more energy can be produced
